Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study.
暂无分享,去创建一个
S. Kugathasan | J. Kierkuś | Toshiaki Shimizu | D. Turner | N. Mostafa | W. Faubion | A. Lazar | F. Ruemmele | N. Croft | T. Finney-Hayward | M. Bereswill | Y. Sanchez Gonzalez | M. Venetucci